Chantal Thys Selected Research

Pseudopseudohypoparathyroidism

4/2012	No evidence for GNAS copy number variants in patients with features of Albright's hereditary osteodystrophy and abnormal platelet Gs activity.
1/2012	Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction.
12/2008	Compound heterozygous mutations in the GNAS gene of a boy with morbid obesity, thyroid-stimulating hormone resistance, pseudohypoparathyroidism, and a prothrombotic state.
12/2008	GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chantal Thys Research Topics

Disease

8	Thrombocytopenia (Thrombopenia) 12/2019 - 03/2004
8	Hemorrhage 05/2019 - 05/2003
4	Pseudopseudohypoparathyroidism 04/2012 - 12/2008
4	Pseudohypoparathyroidism 01/2012 - 10/2002
2	Autism Spectrum Disorder 01/2021 - 01/2015
2	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 03/2016
2	Thrombosis (Thrombus) 06/2006 - 03/2004
1	Neurodevelopmental Disorders 05/2019
1	Erythrokeratodermia Variabilis 01/2019
1	Roifman syndrome 01/2018
1	Neoplasms (Cancer) 03/2016
1	Genetic Translocation (Chromosomal Translocation) 01/2015
1	Alternating hemiplegia of childhood 06/2013
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2013
1	Progressive Osseous Heteroplasia 01/2012
1	Platelet Storage Pool Deficiency 05/2011
1	Morbid Obesity 12/2008
1	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells 12/2007
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 12/2007
1	Intellectual Disability (Idiocy) 03/2004
1	Trisomy (Trisomies) 03/2004
1	Wounds and Injuries (Trauma) 05/2003
1	Brachydactyly 05/2003
1	Hypocalcemia 10/2002
1	Hyperphosphatemia 10/2002
1	Anemia 01/2002

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 04/2012 - 12/2008
3	5-phenylpent-4-enyl-1-hydroperoxideIBA 04/2012 - 12/2008
2	Serotonin (5 Hydroxytryptamine)IBA 05/2019 - 01/2015
2	src-Family KinasesIBA 01/2019 - 03/2016
2	Parathyroid Hormone (Parathormone)IBA 01/2012 - 10/2002
2	CollagenIBA 05/2011 - 02/2008
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2008 - 03/2004
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 05/2019
1	EnzymesIBA 01/2019
1	SphingolipidsIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Small Nuclear RNA (snRNA)IBA 01/2018
1	TubulinIBA 01/2018
1	Pharmaceutical PreparationsIBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	CathepsinsIBA 06/2013
1	CholesterolIBA 01/2013
1	MorpholinosIBA 05/2012
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2011
1	Adenosine Diphosphate (ADP)IBA 05/2011
1	AutoantibodiesIBA 03/2010
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2008
1	AntibodiesIBA 02/2008
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2008
1	Type C PhospholipasesIBA 12/2007
1	GTP-Binding Proteins (G-Protein)IBA 12/2007
1	Hemostatics (Antihemorrhagics)IBA 03/2004
1	Messenger RNA (mRNA)IBA 03/2004
1	NucleotidesIBA 05/2003
1	GATA1 Transcription FactorIBA 01/2002

Therapy/Procedure

1	Therapeutics 02/2008
1	Secondary Prevention 06/2006